KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Other Non-Current Assets: 2015-2025

Historic Other Non-Current Assets for Medpace Holdings (MEDP) over the last 9 years, with Sep 2025 value amounting to $25.7 million.

  • Medpace Holdings' Other Non-Current Assets rose 11.58% to $25.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.7 million, marking a year-over-year increase of 11.58%. This contributed to the annual value of $22.3 million for FY2024, which is 10.88% down from last year.
  • According to the latest figures from Q3 2025, Medpace Holdings' Other Non-Current Assets is $25.7 million, which was up 8.07% from $23.8 million recorded in Q2 2025.
  • In the past 5 years, Medpace Holdings' Other Non-Current Assets registered a high of $25.7 million during Q3 2025, and its lowest value of $13.1 million during Q1 2021.
  • Its 3-year average for Other Non-Current Assets is $22.3 million, with a median of $22.3 million in 2024.
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first skyrocketed by 98.11% in 2021, then dropped by 17.12% in 2024.
  • Over the past 5 years, Medpace Holdings' Other Non-Current Assets (Quarterly) stood at $17.4 million in 2021, then climbed by 21.28% to $21.1 million in 2022, then grew by 18.18% to $25.0 million in 2023, then declined by 10.88% to $22.3 million in 2024, then grew by 11.58% to $25.7 million in 2025.
  • Its last three reported values are $25.7 million in Q3 2025, $23.8 million for Q2 2025, and $21.5 million during Q1 2025.